United States

Optimer Pharmaceuticals LLC (OPTR)

Track

Ticker: OPTR
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
LICHTINGER PEDRO Former CEO
Transaction date
Sale
Price
426.31
Quantity 11,312 +43.2%
Value US$3,224,686
LICHTINGER PEDRO Former CEO
Transaction date
Sale
Price
232.67
Quantity 31,502 -45.5%
Value US$1,553,247
LICHTINGER PEDRO CEO and President Officer
Transaction date
Purchase
Price
451.54
Quantity 42,336 -31.0%
Value US$4,910,816
CHANG JOSEPH Y Non-Executive Director
Transaction date
Sale
Price
15.30
Quantity 3,461 -3.3%
Value US$52,953
ALTIG ANTHONY E Non-Executive Director
Transaction date
Purchase
Price
7.44
Quantity 5,000 +inf%
Value US$37,213
LICHTINGER PEDRO CEO and President Executive Director
Transaction date
Purchase
Price
8.98
Quantity 25,000 +38.0%
Value US$224,450
CHANG JOSEPH Y Non-Executive Director
Transaction date
Sale
Price
11.75
Quantity 3,461 -3.5%
Value US$40,667
CHANG JOSEPH Y Non-Executive Director
Transaction date
Sale
Price
11.75
Quantity 4,615 -4.6%
Value US$54,226
Chang Michael N CEO and President Executive Director
Transaction date
Purchase
Price
10.80
Quantity 8,000 +3.8%
Value US$86,400
Che Tessie M COO and SVP Officer
Transaction date
Purchase
Price
10.80
Quantity 8,000 +3.8%
Value US$86,400
Chang Michael N CEO and President Executive Director
Transaction date
Purchase
Price
10.85
Quantity 10,000 +4.9%
Value US$108,500
Che Tessie M COO and SVP Officer
Transaction date
Purchase
Price
10.85
Quantity 10,000 +4.9%
Value US$108,500
Shue Youe Kong VP, Clinical Development Officer
Transaction date
Purchase
Price
10.89
Quantity 500 +0.6%
Value US$5,445
Shue Youe Kong VP, Clinical Development Officer
Transaction date
Purchase
Price
10.90
Quantity 500 +0.6%
Value US$5,450
Shue Youe Kong VP, Clinical Development Officer
Transaction date
Purchase
Price
10.96
Quantity 1,000 +1.2%
Value US$10,960
Shue Youe Kong VP, Clinical Development Officer
Transaction date
Purchase
Price
11.10
Quantity 1,000 +1.3%
Value US$11,100
Che Tessie M COO and SVP Officer
Transaction date
Purchase
Price
11.50
Quantity 7,000 +3.6%
Value US$80,500
Chang Michael N CEO and President Executive Director
Transaction date
Purchase
Price
11.50
Quantity 7,000 +3.6%
Value US$80,500
Che Tessie M COO and SVP Officer
Transaction date
Purchase
Price
11.53
Quantity 8,000 +4.3%
Value US$92,240
Chang Michael N CEO and President Executive Director
Transaction date
Purchase
Price
11.53
Quantity 8,000 +4.3%
Value US$92,240
SCHREIBER ALAIN Non-Executive Director
Transaction date
Purchase
Price
8.48
Quantity 628,931 +inf%
Value US$5,333,335
SCHREIBER ALAIN Non-Executive Director
Transaction date
Purchase
Price
8.48
Quantity 314,465 +inf%
Value US$2,666,663
EDELMAN JOSEPH Large shareholder
Transaction date
Sale
Price
7.40
Quantity 8,000 -6.6%
Value US$59,200
EDELMAN JOSEPH Large shareholder
Transaction date
Sale
Price
7.40
Quantity 192,000 -7.0%
Value US$1,420,800
Chang Michael N CEO and President Executive Director
Transaction date
Purchase
Price
7.00
Quantity 5,000 +3.0%
Value US$35,000
Che Tessie M COO and SVP Officer
Transaction date
Purchase
Price
7.00
Quantity 5,000 +3.0%
Value US$35,000
Che Tessie M COO & SVP Officer
Transaction date
Planned purchase
Price
6.04
Quantity 2,500 +1.5%
Value US$15,088
Chang Michael N CEO & President Executive Director
Transaction date
Planned purchase
Price
6.04
Quantity 2,042 +0.8%
Value US$12,323
EDELMAN JOSEPH Large shareholder
Transaction date
Sale
Price
7.75
Quantity 12,220 -0.4%
Value US$94,683
EDELMAN JOSEPH Large shareholder
Transaction date
Sale
Price
7.71
Quantity 1,464 -1.2%
Value US$11,292
EDELMAN JOSEPH Large shareholder
Transaction date
Sale
Price
7.71
Quantity 22,936 -0.8%
Value US$176,905
EDELMAN JOSEPH Large shareholder
Transaction date
Sale
Price
7.71
Quantity 756 -0.6%
Value US$5,829
EDELMAN JOSEPH Large shareholder
Transaction date
Sale
Price
7.71
Quantity 11,844 -0.4%
Value US$91,321
EDELMAN JOSEPH Large shareholder
Transaction date
Sale
Price
7.75
Quantity 780 -0.6%
Value US$6,044
EDELMAN JOSEPH Large shareholder
Transaction date
Sale
Price
7.38
Quantity 348 -0.3%
Value US$2,569
EDELMAN JOSEPH Large shareholder
Transaction date
Sale
Price
7.38
Quantity 5,452 -0.2%
Value US$40,245
Chang Michael N CEO Executive Director
Transaction date
Purchase
Price
5.95
Quantity 1,000 +0.4%
Value US$5,950
Che Tessie M COO Officer
Transaction date
Planned purchase
Price
5.95
Quantity 1,000 +0.6%
Value US$5,950
Chang Michael N CEO Executive Director
Transaction date
Purchase
Price
5.95
Quantity 1,000 +0.6%
Value US$5,950
Poulos Kevin P Chief Commercial Officer Officer
Transaction date
Planned purchase
Price
5.95
Quantity 1,000 +166.7%
Value US$5,950
Che Tessie M COO Officer
Transaction date
Planned purchase
Price
5.95
Quantity 1,000 +0.4%
Value US$5,950
Prunty John D CFO Officer
Transaction date
Planned purchase
Price
5.95
Quantity 1,000 +inf%
Value US$5,950
Shue Youe Kong VP Clinical Development Officer
Transaction date
Planned purchase
Price
5.95
Quantity 1,000 +1.3%
Value US$5,950
Shue Youe Kong VP Clinical Development Officer
Transaction date
Purchase
Price
8.24
Quantity 300 +0.4%
Value US$2,472
Shue Youe Kong VP Clinical Development Officer
Transaction date
Purchase
Price
8.27
Quantity 200 +0.3%
Value US$1,654
Shue Youe Kong VP Clinical Development Officer
Transaction date
Purchase
Price
8.28
Quantity 100 +0.1%
Value US$828
Shue Youe Kong VP Clinical Development Officer
Transaction date
Purchase
Price
8.29
Quantity 200 +0.3%
Value US$1,658
Shue Youe Kong VP Clinical Development Officer
Transaction date
Purchase
Price
8.30
Quantity 1,200 +1.7%
Value US$9,960
Shue Youe Kong VP Clinical Development Officer
Transaction date
Purchase
Price
8.30
Quantity 500 +0.7%
Value US$4,150
Chang Michael N President & CEO Executive Director
Transaction date
Purchase
Price
8.20
Quantity 30,000 +21.5%
Value US$246,000
Che Tessie M Senior VP & COO Officer
Transaction date
Purchase
Price
8.20
Quantity 30,000 +21.5%
Value US$246,000
Che Tessie M Senior VP & COO Officer
Transaction date
Purchase
Price
9.05
Quantity 10,000 +7.7%
Value US$90,500
Chang Michael N President and CEO Executive Director
Transaction date
Purchase
Price
9.05
Quantity 10,000 +7.7%
Value US$90,500
Che Tessie M Senior VP & COO Officer
Transaction date
Purchase
Price
9.80
Quantity 5,000 +4.0%
Value US$49,000
Che Tessie M Senior VP & COO Officer
Transaction date
Purchase
Price
9.92
Quantity 5,000 +4.2%
Value US$49,600
Chang Michael N President, CEO Executive Director
Transaction date
Purchase
Price
9.80
Quantity 5,000 +4.0%
Value US$49,000
Chang Michael N President, CEO Executive Director
Transaction date
Purchase
Price
9.92
Quantity 5,000 +4.2%
Value US$49,600
Par Pharmacuetical, Inc. Large shareholder
Transaction date
Sale
Price
7.00
Quantity 1,050,000 -45.5%
Value US$7,350,000
Chang Michael N President, CEO Executive Director
Transaction date
Purchase
Price
7.00
Quantity 114,965 +2491.1%
Value US$804,755
Poulos Kevin P VP, Marketing and Sales Officer
Transaction date
Purchase
Price
7.00
Quantity 600 +inf%
Value US$4,200
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2013-04-10 2013-04-08 S Sale LICHTINGER PEDRO

Former CEO
11,312 +43.2%
426.31
US$3,224,686 		11,312 +43.2% 426.31 US$3,224,686
2013-04-10 2013-04-08 S Sale LICHTINGER PEDRO

Former CEO
31,502 -45.5%
232.67
US$1,553,247 		31,502 -45.5% 232.67 US$1,553,247
2012-11-19 2012-11-08 B Purchase LICHTINGER PEDRO

CEO and President

Officer
42,336 -31.0%
451.54
US$4,910,816 		42,336 -31.0% 451.54 US$4,910,816
2012-06-20 2012-06-11 S Sale CHANG JOSEPH Y Non-Executive Director
3,461 -3.3%
15.30
US$52,953 		3,461 -3.3% 15.30 US$52,953
2011-08-09 2011-08-09 B Purchase ALTIG ANTHONY E Non-Executive Director
5,000 +inf%
7.44
US$37,213 		5,000 +inf% 7.44 US$37,213
2011-08-04 2011-08-04 B Purchase LICHTINGER PEDRO

CEO and President

Executive Director
25,000 +38.0%
8.98
US$224,450 		25,000 +38.0% 8.98 US$224,450
2010-05-13 2010-05-12 S Sale CHANG JOSEPH Y Non-Executive Director
3,461 -3.5%
11.75
US$40,667 		3,461 -3.5% 11.75 US$40,667
2010-05-13 2010-05-12 S Sale CHANG JOSEPH Y Non-Executive Director
4,615 -4.6%
11.75
US$54,226 		4,615 -4.6% 11.75 US$54,226
2009-12-29 2009-12-29 B Purchase Chang Michael N

CEO and President

Executive Director
8,000 +3.8%
10.80
US$86,400 		8,000 +3.8% 10.80 US$86,400
2009-12-29 2009-12-29 B Purchase Che Tessie M

COO and SVP

Officer
8,000 +3.8%
10.80
US$86,400 		8,000 +3.8% 10.80 US$86,400
2009-12-29 2009-12-28 B Purchase Chang Michael N

CEO and President

Executive Director
10,000 +4.9%
10.85
US$108,500 		10,000 +4.9% 10.85 US$108,500
2009-12-29 2009-12-28 B Purchase Che Tessie M

COO and SVP

Officer
10,000 +4.9%
10.85
US$108,500 		10,000 +4.9% 10.85 US$108,500
2009-12-02 2009-12-02 B Purchase Shue Youe Kong

VP, Clinical Development

Officer
500 +0.6%
10.89
US$5,445 		500 +0.6% 10.89 US$5,445
2009-12-02 2009-12-02 B Purchase Shue Youe Kong

VP, Clinical Development

Officer
500 +0.6%
10.90
US$5,450 		500 +0.6% 10.90 US$5,450
2009-12-02 2009-12-02 B Purchase Shue Youe Kong

VP, Clinical Development

Officer
1,000 +1.2%
10.96
US$10,960 		1,000 +1.2% 10.96 US$10,960
2009-12-02 2009-12-01 B Purchase Shue Youe Kong

VP, Clinical Development

Officer
1,000 +1.3%
11.10
US$11,100 		1,000 +1.3% 11.10 US$11,100
2009-11-25 2009-11-25 B Purchase Che Tessie M

COO and SVP

Officer
7,000 +3.6%
11.50
US$80,500 		7,000 +3.6% 11.50 US$80,500
2009-11-25 2009-11-25 B Purchase Chang Michael N

CEO and President

Executive Director
7,000 +3.6%
11.50
US$80,500 		7,000 +3.6% 11.50 US$80,500
2009-11-25 2009-11-25 B Purchase Che Tessie M

COO and SVP

Officer
8,000 +4.3%
11.53
US$92,240 		8,000 +4.3% 11.53 US$92,240
2009-11-25 2009-11-25 B Purchase Chang Michael N

CEO and President

Executive Director
8,000 +4.3%
11.53
US$92,240 		8,000 +4.3% 11.53 US$92,240
2008-07-22 2008-07-18 B Purchase SCHREIBER ALAIN Non-Executive Director
628,931 +inf%
8.48
US$5,333,335 		628,931 +inf% 8.48 US$5,333,335
2008-07-22 2008-07-18 B Purchase SCHREIBER ALAIN Non-Executive Director
314,465 +inf%
8.48
US$2,666,663 		314,465 +inf% 8.48 US$2,666,663
2008-07-25 2008-07-02 S Sale EDELMAN JOSEPH Large shareholder
8,000 -6.6%
7.40
US$59,200 		8,000 -6.6% 7.40 US$59,200
2008-07-25 2008-07-02 S Sale EDELMAN JOSEPH Large shareholder
192,000 -7.0%
7.40
US$1,420,800 		192,000 -7.0% 7.40 US$1,420,800
2008-06-17 2008-06-13 B Purchase Chang Michael N

CEO and President

Executive Director
5,000 +3.0%
7.00
US$35,000 		5,000 +3.0% 7.00 US$35,000
2008-06-17 2008-06-13 B Purchase Che Tessie M

COO and SVP

Officer
5,000 +3.0%
7.00
US$35,000 		5,000 +3.0% 7.00 US$35,000
2008-05-16 2008-05-15 PP Planned purchase Che Tessie M

COO & SVP

Officer
2,500 +1.5%
6.04
US$15,088 		2,500 +1.5% 6.04 US$15,088
2008-05-16 2008-05-15 PP Planned purchase Chang Michael N

CEO & President

Executive Director
2,042 +0.8%
6.04
US$12,323 		2,042 +0.8% 6.04 US$12,323
2007-12-27 2007-12-19 S Sale EDELMAN JOSEPH Large shareholder
12,220 -0.4%
7.75
US$94,683 		12,220 -0.4% 7.75 US$94,683
2007-12-27 2007-12-18 S Sale EDELMAN JOSEPH Large shareholder
1,464 -1.2%
7.71
US$11,292 		1,464 -1.2% 7.71 US$11,292
2007-12-27 2007-12-18 S Sale EDELMAN JOSEPH Large shareholder
22,936 -0.8%
7.71
US$176,905 		22,936 -0.8% 7.71 US$176,905
2007-12-27 2007-12-17 S Sale EDELMAN JOSEPH Large shareholder
756 -0.6%
7.71
US$5,829 		756 -0.6% 7.71 US$5,829
2007-12-27 2007-12-17 S Sale EDELMAN JOSEPH Large shareholder
11,844 -0.4%
7.71
US$91,321 		11,844 -0.4% 7.71 US$91,321
2007-12-27 2007-12-13 S Sale EDELMAN JOSEPH Large shareholder
780 -0.6%
7.75
US$6,044 		780 -0.6% 7.75 US$6,044
2007-12-27 2007-12-13 S Sale EDELMAN JOSEPH Large shareholder
348 -0.3%
7.38
US$2,569 		348 -0.3% 7.38 US$2,569
2007-12-27 2007-12-13 S Sale EDELMAN JOSEPH Large shareholder
5,452 -0.2%
7.38
US$40,245 		5,452 -0.2% 7.38 US$40,245
2007-11-19 2007-11-15 B Purchase Chang Michael N

CEO

Executive Director
1,000 +0.4%
5.95
US$5,950 		1,000 +0.4% 5.95 US$5,950
2007-11-19 2007-11-15 PP Planned purchase Che Tessie M

COO

Officer
1,000 +0.6%
5.95
US$5,950 		1,000 +0.6% 5.95 US$5,950
2007-11-19 2007-11-15 B Purchase Chang Michael N

CEO

Executive Director
1,000 +0.6%
5.95
US$5,950 		1,000 +0.6% 5.95 US$5,950
2007-11-19 2007-11-15 PP Planned purchase Poulos Kevin P

Chief Commercial Officer

Officer
1,000 +166.7%
5.95
US$5,950 		1,000 +166.7% 5.95 US$5,950
2007-11-19 2007-11-15 PP Planned purchase Che Tessie M

COO

Officer
1,000 +0.4%
5.95
US$5,950 		1,000 +0.4% 5.95 US$5,950
2007-11-19 2007-11-15 PP Planned purchase Prunty John D

CFO

Officer
1,000 +inf%
5.95
US$5,950 		1,000 +inf% 5.95 US$5,950
2007-11-19 2007-11-15 PP Planned purchase Shue Youe Kong

VP Clinical Development

Officer
1,000 +1.3%
5.95
US$5,950 		1,000 +1.3% 5.95 US$5,950
2007-08-13 2007-08-10 B Purchase Shue Youe Kong

VP Clinical Development

Officer
300 +0.4%
8.24
US$2,472 		300 +0.4% 8.24 US$2,472
2007-08-13 2007-08-10 B Purchase Shue Youe Kong

VP Clinical Development

Officer
200 +0.3%
8.27
US$1,654 		200 +0.3% 8.27 US$1,654
2007-08-13 2007-08-10 B Purchase Shue Youe Kong

VP Clinical Development

Officer
100 +0.1%
8.28
US$828 		100 +0.1% 8.28 US$828
2007-08-13 2007-08-10 B Purchase Shue Youe Kong

VP Clinical Development

Officer
200 +0.3%
8.29
US$1,658 		200 +0.3% 8.29 US$1,658
2007-08-13 2007-08-10 B Purchase Shue Youe Kong

VP Clinical Development

Officer
1,200 +1.7%
8.30
US$9,960 		1,200 +1.7% 8.30 US$9,960
2007-08-13 2007-08-09 B Purchase Shue Youe Kong

VP Clinical Development

Officer
500 +0.7%
8.30
US$4,150 		500 +0.7% 8.30 US$4,150
2007-08-10 2007-08-09 B Purchase Chang Michael N

President & CEO

Executive Director
30,000 +21.5%
8.20
US$246,000 		30,000 +21.5% 8.20 US$246,000
2007-08-10 2007-08-09 B Purchase Che Tessie M

Senior VP & COO

Officer
30,000 +21.5%
8.20
US$246,000 		30,000 +21.5% 8.20 US$246,000
2007-08-08 2007-08-06 B Purchase Che Tessie M

Senior VP & COO

Officer
10,000 +7.7%
9.05
US$90,500 		10,000 +7.7% 9.05 US$90,500
2007-08-08 2007-08-06 B Purchase Chang Michael N

President and CEO

Executive Director
10,000 +7.7%
9.05
US$90,500 		10,000 +7.7% 9.05 US$90,500
2007-08-08 2007-07-16 B Purchase Che Tessie M

Senior VP & COO

Officer
5,000 +4.0%
9.80
US$49,000 		5,000 +4.0% 9.80 US$49,000
2007-08-08 2007-07-16 B Purchase Che Tessie M

Senior VP & COO

Officer
5,000 +4.2%
9.92
US$49,600 		5,000 +4.2% 9.92 US$49,600
2007-07-18 2007-07-16 B Purchase Chang Michael N

President, CEO

Executive Director
5,000 +4.0%
9.80
US$49,000 		5,000 +4.0% 9.80 US$49,000
2007-07-18 2007-07-16 B Purchase Chang Michael N

President, CEO

Executive Director
5,000 +4.2%
9.92
US$49,600 		5,000 +4.2% 9.92 US$49,600
2007-02-23 2007-02-21 S Sale Par Pharmacuetical, Inc. Large shareholder
1,050,000 -45.5%
7.00
US$7,350,000 		1,050,000 -45.5% 7.00 US$7,350,000
2007-02-14 2007-02-14 B Purchase Chang Michael N

President, CEO

Executive Director
114,965 +2491.1%
7.00
US$804,755 		114,965 +2491.1% 7.00 US$804,755
2007-02-14 2007-02-14 B Purchase Poulos Kevin P

VP, Marketing and Sales

Officer
600 +inf%
7.00
US$4,200 		600 +inf% 7.00 US$4,200
Explore more

More insider trading research around Optimer Pharmaceuticals LLC

More insider trades in United States
Insider trading in North America